news
Groundbreaking data tool may uncover novel class of GPCRs
A new computer-aided tool maps allosteric sites in G protein-coupled receptors to search for allosteric drugs to treat a range of diseases.
List view / Grid view
Queen's University Belfast
news
Researchers discover process viruses use to block antiviral immune response
A team has revealed that viruses ‘hijack’ a molecular process in the cell, inhibiting the body’s response to viral infection.
news
Researchers take a leap forward for new anti-inflammatory drugs
Treatments for chronic inflammatory diseases are one step closer as a new study discovers a way to stop inflammation in its tracks.
news
Queen’s researchers breakthrough discovery in fight against bowel cancer
New research led by Queen’s University Belfast has discovered how a genomic approach to understanding bowel cancer could improve the prognosis and quality of life for patients.
news
Study shows potential of stem cell therapy to repair lung damage
A new study has found that stem cell therapy can reduce lung inflammation in an animal model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Although, still at a pre-clinical stage, these findings have important potential implications for the future treatment of patients.
news
Increased protein activity makes bowel cancer drug resistant
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Blocking a molecule could bypass bowel cancer’s defence against the drug cetuximab, according to new research presented at the National Cancer Research...
news
CV drug Darapladib shows potential in diabetic macular oedema
14 June 2016 | By Victoria White, Digital Content Producer
The discovery demonstrates that Darapladib has potential to provide protection against vision loss in a much wider group of patients with diabetes...
news
DNA from 20,000 people to help discover new treatments for diabetic kidney disease
3 June 2016 | By Victoria White, Digital Content Producer
Researchers are to examine DNA samples from 20,000 people with diabetes to help identify the genetic factors in diabetic kidney disease...
news
New €2.25m international project to tackle diabetes-related blindness
28 April 2016 | By Victoria White, Digital Content Producer
A new €2.25m US-Ireland R&D partnership has been set up to develop a gene therapy approach with the aim of potentially reversing diabetes-related blindness...
article
Advancing FLIP inhibitors for the treatment of NSCLC
26 April 2016 | By Victoria White, Drug Target Review
In an exclusive interview, Trevor Perrior, Research Director at Domainex, discusses the cell death regulatory protein FLIP and the potential of FLIP inhibitors as a treatment for NSCLC...
news
Queen’s University Belfast and Domainex secure award to advance FLIP inhibitor
26 April 2016 | By Victoria White, Digital Content Producer
Queen’s University Belfast and Domainex have secured an award to advance therapeutic candidate molecules into clinical evaluation for treatment of NSCLC...
